CYBB gene editing therapy (Trucode Gene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCYBB gene editing therapy (Trucode Gene)
Drug Alias NameNADPH-oxidase/gp91phox gene editing therapy (Trucode Gene)NOX2 gene editing therapy (Trucode Gene)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionCYBB gene stimulants
TargetsNADPH Oxidase 2
Therapy Area/IndicationsGranulomatous Disease, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrucode Gene Repair Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrucode Gene Repair Inc
Active IndicationsN/A
Inactive IndicationsGranulomatous Disease, Chronic

Other Information

ATC CodeN/A
Related LinksN/A